RA PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
RA PHARMACEUTICALS, INC. reported Increase (Decrease) in Deferred Revenue of -$1.86 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-14
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was $0.00.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was $0.00.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was -$37.00K.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-03-31 was -$1.82M.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$1.86M.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$883.00K.
- RA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2014 was -$1.53M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | -$37.00K derived: sum of 3 quarters · filed 2018-03-14 | -$1.86M 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$37.00K derived: sum of 2 quarters · filed 2017-11-09 | -$1.86M 10-Q · filed 2017-11-09 | -$2.65M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.86M 10-Q · filed 2017-08-09 | -$2.65M derived: sum of 3 quarters · filed 2018-03-14 | |
| 2016-03-31 | -$1.82M 10-Q · filed 2017-05-11 | -$2.61M derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2015-12-31 | -$787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$883.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | -$96.00K 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | -$1.53M 10-K · filed 2017-03-06 |